Skip to content

Clinical trials

Phase 3 Lupus Erythematosus, Systemic trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 3 Country / region: Romania Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20081
20102
20113
20181
20191
20202
20212
20223
20233
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting6
Recruiting4
Enrolling by invitation3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Eli Lilly and Company3
UCB Pharma3
Biogen2
EMD Serono Research & Development Institute, Inc.2
Human Genome Sciences Inc.2
Human Genome Sciences Inc., a GSK Company2
UCB Biopharma SRL2
Viatris Innovation GmbH2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic26
Autoimmune Diseases8
Connective Tissue Diseases5
Immune System Diseases5
Lupus Nephritis3
Lupus Erythematosus, Cutaneous2
Lupus Erythematosus, Discoid2
Nephritis2
Skin and Connective Tissue Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.